| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 2/6 |
1SKF401E Stock Overview
Zentiva, a.s. develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally.
Zentiva, a.s. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €25.00 |
| 52 Week High | €35.00 |
| 52 Week Low | €11.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -91.94% |
| Change since IPO | -97.50% |
Recent News & Updates
Shareholder Returns
| 1SKF401E | SK Pharmaceuticals | SK Market | |
|---|---|---|---|
| 7D | 0% | -2.6% | 0.008% |
| 1Y | n/a | 4.4% | 3.1% |
Return vs Industry: Insufficient data to determine how 1SKF401E performed against the SK Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1SKF401E performed against the SK Market.
Price Volatility
| 1SKF401E volatility | |
|---|---|
| 1SKF401E Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in SK Market | 10.4% |
| 10% least volatile stocks in SK Market | 2.9% |
Stable Share Price: Insufficient data to determine 1SKF401E's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine 1SKF401E's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | n/a | https://www.zentiva.sk |
Zentiva, a.s. develops, manufactures, and sells generic medicinal products, primarily used in primary care sector in Slovak, Czech Republic, and internationally. The company offers prescription medicines. It also engages in the production and wholesaling of pharmaceuticals and chemical products.
Zentiva, a.s. Fundamentals Summary
| 1SKF401E fundamental statistics | |
|---|---|
| Market Cap | €40.50m |
| Earnings (TTM) | €2.29m |
| Revenue (TTM) | €36.17m |
0.0x
P/E Ratio0.0x
P/S RatioIs 1SKF401E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1SKF401E income statement (TTM) | |
|---|---|
| Revenue | €36.17m |
| Cost of Revenue | €13.50m |
| Gross Profit | €22.67m |
| Other Expenses | €20.38m |
| Earnings | €2.29m |
Last Reported Earnings
Dec 31, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 1SKF401E perform over the long term?
See historical performance and comparison